Giant Cell Arteritis
What's New
Last Posted: Dec 18, 2024
- Higher risk profile among patients with TET2-mutated giant cell arteritis: a cluster analysis.
Alexis F Guedon, et al. RMD open 2024 0 (4) - Polymyalgia rheumatica and giant cell arteritis: A bidirectional Mendelian randomization study.
Lin Teng, et al. Medicine 2024 0 (38) e39723 - Estimating overdiagnosis in giant cell arteritis diagnostic pathways using genetic data: genetic association study.
Charikleia Chatzigeorgiou, et al. Rheumatology (Oxford, England) 2023 0 - Somatic TET2 Mutations are Associated with Giant Cell Arteritis.
Michelle L Robinette, et al. Arthritis & rheumatology (Hoboken, N.J.) 2023 0 - Clonal hematopoiesis and UBA1 mutations in individuals with biopsy-proven giant cell arteritis and population-based controls.
Jonas B Salzbrunn, et al. Rheumatology (Oxford, England) 2023 0 - Cranial and extracranial giant cell arteritis do not exhibit differences in the IL6 -174 G/C gene polymorphism.
Genre Fernanda, et al. Clinical and experimental rheumatology 2023 0 - The role of a functional variant of TYK2 in vasculitides and infections.
Ortiz-Fernández Lourdes, et al. Clinical and experimental rheumatology 2020 0 (5) 949-955 - HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study.
Kushimoto Kazuo, et al. Arthritis research & therapy 2021 0 (1) 238 - Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway.
Prieto-Peña Diana, et al. Clinical and experimental rheumatology 2022 0 - The Association Between the PTPN22 C1858T Variant and Vasculitis: A Meta-analysis Update with Trial Sequential Analysis.
Lee Young Ho, et al. Genetic testing and molecular biomarkers 2022 0 (10) 492-500 - Vascular endothelial growth factor haplotypes are associated with severe ischaemic complications in giant cell arteritis regardless of the disease phenotype.
Prieto-Peña Diana, et al. Clinical and experimental rheumatology 2022 0 (4) 727-733 - Association of autoimmune diseases with Alzheimer's disease: A mendelian randomization study.
Yeung Chris Ho Ching, et al. Journal of psychiatric research 2022 9 550-558 - Cross-phenotype analysis of Immunochip data identifies KDM4C as a relevant locus for the development of systemic vasculitis.
Ortiz-Fernández Lourdes, et al. Annals of the rheumatic diseases 2018 0 (4) 589-595 - Myeloproliferative neoplasms and clonal haematopoiesis in patients with giant cell arteritis: a case-control and exploratory study.
Papo Matthias, et al. Rheumatology (Oxford, England) 2021 4 - The presence of both HLA-DRB1*04:01 and HLA-B*15:01 increases the susceptibility to cranial and extracranial giant cell arteritis.
Prieto-Peña Diana, et al. Clinical and experimental rheumatology 2021 3 - Familial risks between giant cell arteritis and Takayasu arteritis and other autoimmune diseases in the population of Sweden.
Thomsen Hauke et al. Scientific reports 2020 10(1) 20887 - Cranial and extracranial giant cell arteritis share similar HLA-DRB1 association.
Prieto-Peña Diana, et al. Seminars in arthritis and rheumatism 2020 7 (5) 897-901 - Colour Doppler ultrasound of temporal arteries for the diagnosis of giant cell arteritis: a multicentre deep learning study.
Roncato Christophe et al. Clinical and experimental rheumatology 38 Suppl 124(2) 120-125 - Influence of IL17A gene on the pathogenesis of immunoglobulin-A vasculitis.
López-Mejías Raquel, et al. Clinical and experimental rheumatology 2020 3 - A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility.
González-Serna David, et al. PloS one 2018 0 (12) e0209343
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: